| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |